AvalehtDEVA • IST
add
Deva Holding AS
Viimane sulgemishind
67,10 ₺
Tänane vahemik
66,10 ₺ - 68,00 ₺
Aasta vahemik
51,00 ₺ - 81,75 ₺
Turuväärtus
13,41 mld TRY
Keskmine maht
637,03 tuh
P/E suhe
-
Dividendimäär
-
Põhibörs
IST
Börsiuudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (TRY) | dets 2025info | Y/Y muutus |
|---|---|---|
Käive | 5,49 mld | −2,19% |
Põhitegevusega seonduv kulu | 1,74 mld | 2,67% |
Puhastulu | −1,34 mld | −524,24% |
Puhaskasumimarginaal | −24,48 | −537,50% |
Puhaskasum aktsia kohta | — | — |
EBITDA | 622,26 mln | −48,71% |
Tõhus maksumäär | −294,28% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (TRY) | dets 2025info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 3,59 mld | 26,49% |
Kogu vara | 37,63 mld | −3,31% |
Kõik kohustused | 11,31 mld | −3,14% |
Kogu omakapital | 26,32 mld | — |
Emiteeritud aktsiate arv | 200,02 mln | — |
Hinna ja väärtuse suhe P/B | 0,51 | — |
Varade tasuvus | −0,61% | — |
Kapitali tasuvus | −0,70% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (TRY) | dets 2025info | Y/Y muutus |
|---|---|---|
Puhastulu | −1,34 mld | −524,24% |
Põhitegevuse rahakäive | 1,49 mld | 27,32% |
Investeeringute raha | −838,87 mln | −130,98% |
Finantseerimise raha | 260,62 mln | 117,90% |
Raha ja raha ekvivalentide muutus | 885,62 mln | 206,74% |
Tasuta rahavoog | −165,38 mln | 95,31% |
Teave
DEVA Holding A.Ş. is a leading Turkish pharmaceutical company founded in 1958. As of 2024, it ranked 3rd in unit sales and 6th in TL sales in Turkey’s pharmaceutical market.
The company operates three EU GMP- and US FDA-approved facilities in Çerkezköy and Kartepe, with an annual production capacity of 620 million units. DEVA’s portfolio covers 10 therapeutic areas, including cardiovascular, dermatology, ophthalmology, hematology, and anti-infectives, and includes 1,404 registered products across 82 countries.
Recognized as Turkey’s top pharmaceutical company in R&D spending by Turkishtime’s 2024 R&D 250 Report, DEVA employs over 500 researchers and 3,000 staff in total. Guided by sustainability and innovation, the company focuses on developing accessible, effective, and environmentally responsible healthcare solutions for both domestic and global markets. Wikipedia
Asutatud
22. sept 1958
Veebisait
Töötajate arv
3 023
